MassMutual Private Wealth & Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1M Sell
52,114
-1,049
-2% -$504K 0.68% 38
2026
Q1
$26.1M Sell
53,163
-411
-0.8% -$223K 0.71% 38
2025
Q4
$31M Sell
53,574
-720
-1% -$407K 0.8% 33
2025
Q3
$26.3M Buy
54,294
+1,150
+2% +$535K 0.67% 40
2025
Q2
$21.5M Buy
53,144
+1,384
+3% +$579K 0.57% 46
2025
Q1
$25.8M Buy
51,760
+3,829
+8% +$2.07M 0.75% 40
2024
Q4
$24.9M Sell
47,931
-3,514
-7% -$1.93M 0.7% 40
2024
Q3
$31.8M Buy
51,445
+1,146
+2% +$678K 0.91% 28
2024
Q2
$27.8M Buy
50,299
+85
+0.2% +$48.7K 0.84% 28
2024
Q1
$29.2M Buy
50,214
+2,385
+5% +$1.34M 0.91% 29
2023
Q4
$25.4M Sell
47,829
-601
-1% -$291K 0.85% 29
2023
Q3
$24.5M Buy
48,430
+866
+2% +$461K 0.91% 29
2023
Q2
$24.8M Sell
47,564
-3,180
-6% -$1.72M 0.89% 27
2023
Q1
$29.2M Buy
50,744
+716
+1% +$404K 1.12% 22
2022
Q4
$27.6M Buy
50,028
+137
+0.3% +$72.6K 1.13% 21
2022
Q3
$25.3M Buy
49,891
+836
+2% +$468K 1.15% 22
2022
Q2
$26.7M Buy
49,055
+2,108
+4% +$1.16M 1.15% 21
2022
Q1
$27.7M Buy
46,947
+655
+1% +$376K 1.05% 22
2021
Q4
$30.9M Buy
46,292
+1,126
+2% +$703K 1.15% 19
2021
Q3
$25.8M Buy
45,166
+2,770
+7% +$1.52M 1.07% 20
2021
Q2
$21.4M Buy
42,396
+4,417
+12% +$2.08M 0.91% 31
2021
Q1
$17.3M Buy
37,979
+2,586
+7% +$1.23M 0.82% 33
2020
Q4
$16.5M Buy
35,393
+1,037
+3% +$486K 0.84% 29
2020
Q3
$15.2M Sell
34,356
-426
-1% -$176K 0.89% 26
2020
Q2
$12.6M Buy
34,782
+2,829
+9% +$948K 0.81% 30
2020
Q1
$9.06M Buy
31,953
+5,487
+21% +$1.73M 0.72% 35
2019
Q4
$8.6M Buy
26,466
+781
+3% +$237K 0.53% 45
2019
Q3
$7.48M Buy
25,685
+481
+2% +$138K 0.5% 50
2019
Q2
$7.4M Buy
25,204
+4,297
+21% +$1.18M 0.51% 47
2019
Q1
$5.72M Buy
20,907
+5,128
+32% +$1.28M 0.41% 61
2018
Q4
$3.53M Buy
15,779
+320
+2% +$75.1K 0.3% 86
2018
Q3
$3.77M Buy
15,459
+2,420
+19% +$557K 0.28% 92
2018
Q2
$2.7M Buy
13,039
+12,834
+6,260% +$2.72M 0.22% 114
2018
Q1
$42.3K Sell
205
-25
-11% -$5.25K ﹤0.01% 428
2017
Q4
$43.7K Buy
230
+125
+119% +$23.9K ﹤0.01% 458
2017
Q3
$19.9K Hold
105
﹤0.01% 652
2017
Q2
$18.3K Buy
105
+35
+50% +$5.88K ﹤0.01% 633
2017
Q1
$10.8K Sell
70
-285
-80% -$43.6K ﹤0.01% 693
2016
Q4
$50.1K Buy
+355
New +$52.3K 0.01% 357
2016
Q2
$17.9K Sell
121
-67
-36% -$9.89K ﹤0.01% 464
2016
Q1
$26.6K Sell
188
-337
-64% -$45.2K ﹤0.01% 421
2015
Q4
$74.5K Buy
525
+177
+51% +$23.6K 0.01% 341
2015
Q3
$42.4K Buy
348
+143
+70% +$18.6K 0.01% 391
2015
Q2
$24.2K Sell
205
-143
-41% -$18.6K 0.01% 406
2015
Q1
$46.8K Hold
348
0.01% 364
2014
Q4
$43.6K Hold
348
0.01% 267
2014
Q3
$42.4K Buy
348
+143
+70% +$17.4K 0.01% 382
2014
Q2
$24.2K Hold
205
0.01% 282
2014
Q1
$24.6K Sell
205
-24
-10% -$2.85K 0.01% 251
2013
Q4
$25.5K Buy
+229
New +$22.8K 0.02% 228

Other funds holding TMO

MassMutual Private Wealth & Trust's TMO Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q2 2026, selling an estimated $504K and leaving 52,114 shares worth $26.1M. The position accounts for 0.68% of the portfolio, ranked #38.

MassMutual Private Wealth & Trust first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $31.8M in Q3 2024. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MassMutual Private Wealth & Trust held 52,114 shares of Thermo Fisher Scientific worth $26.1M as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 1,049 Thermo Fisher Scientific shares in Q2 2026, an estimated $504K.
  • Thermo Fisher Scientific made up 0.68% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #38 holding.
  • MassMutual Private Wealth & Trust first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
  • MassMutual Private Wealth & Trust's Thermo Fisher Scientific position peaked at $31.8M in Q3 2024.
  • 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.